Drug Database
Back to search

United Kingdom· GB-APID-20442211000001103

Rifaximin 550mg tablets

A rifaximin product containing rifaximin, registered in United Kingdom by Special Order. The same ATC class is registered in 14 of our 19 countries.

ATC A07AA11

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedRifaximin 550mg tabletsATCA07AA11REGISTER NO.GB-APID-2044221100000…PACKS LISTED0CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about rifaximinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rifaximin is registered in 14 of 19 countries.

Countries holding a registration under ATC A07AA11 (rifaximin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 7 of them publish a price we can compare per daily dose
Search rifaximin products by name

Rifaximin · ATC A07AA11

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rifaximin costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Rifaximin · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

  • CH Switzerland$7.02
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Rifaximin
Manufacturer
Special Order
Country
United Kingdom (GB)
ATC code
A07AA11
ATC class
Rifaximin
Defined daily dose
0.6 g, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

88 interactions on record for rifaximin.

Graded by severity as the source publishes them — 63 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rifaximin against other medicinesHow interaction checks work

Rifaximin · interactions on record

88 records

  • 63 moderate
  • 25 info

Most severe, free to view

  • RolapitantA04AD14moderate
  • Sodium picosulfateA06AB08moderate
  • EliglustatA16AX10moderate
  • LonafarnibA16AX20moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rifaximin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rifaximin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Colidimin, Refero
  • Belgium · Targaxan, Tixteller
  • Czechia · Normix
  • Germany · Rifaxan, Tixteller
  • Denmark · Faxinorm, Xifaxan
  • Spain · Spiraxin, Tixtar
  • Finland · Targaxan, Xifaxan
  • France · Tixtar
  • Greece · Rifacol
  • Hungary · Normix, Refero
  • Ireland · Rifaximin Alfasigma, Targaxan
  • Italy · Flonorm, Normix
  • Luxembourg · Refero, Targaxan
  • Netherlands · Tixteller, Xifaxan
  • Norway · Xifaxan
  • Poland · Tixteller, Xifaxan
  • Portugal · Refero, Xifaxan
  • Romania · Normix, Tixteller
  • Sweden · Xifaxan
  • Slovakia · Normix, Refero

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/199446e2-5ed5-4021-bf4b-29a08c90c319
GET /v1/drugs/199446e2-5ed5-4021-bf4b-29a08c90c319?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "20442211000001103",
  "desc": "Rifaximin 550mg tablets (Special Order)",
  "form": "Oral tablet",
  "vpid": "41955011000001108",
  "source": "dmd",
  "vtm_id": "777440004",
  "strength": "550 mg",
  "substance": "Rifaximin",
  "ingredient": "Rifaximin",
  "supplier_code": "8286711000001104"
}
API referenceMCP serverPlans

See everything about rifaximin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console